Diagnosing overdiagnosis: conceptual challenges and suggested solutions

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3

References

  1. 1.

    Moynihan R, Doust J, Henry D. Preventing overdiagnosis: how to stop harming the healthy. BMJ. 2012;344:e3502. doi:10.1136/bmj.e3502.

    PubMed  Article  Google Scholar 

  2. 2.

    Welch HG, Schwartz L, Woloshin S. Overdiagnosed : making people sick in the pursuit of health. Boston: Beacon Press; 2011.

    Google Scholar 

  3. 3.

    Berwick DM, Hackbarth AD. Eliminating waste in US health care. JAMA. 2012;307(14):1513–6. doi:10.1001/jama.2012.362.

    PubMed  Article  CAS  Google Scholar 

  4. 4.

    Bloche MG. Beyond the “R word”? Medicine’s new frugality. N Engl J Med. 2012;366(21):1951–3. doi:10.1056/NEJMp1203521.

    PubMed  Article  CAS  Google Scholar 

  5. 5.

    Fisher ES, Wennberg DE, Stukel TA, Gottlieb DJ, Lucas FL, Pinder EL. The implications of regional variations in medicare spending. Part 2: health outcomes and satisfaction with care. Ann Intern Med. 2003;138(4):288–98.

    PubMed  Article  Google Scholar 

  6. 6.

    Puliti D, Zappa M, Miccinesi G, Falini P, Crocetti E, Paci E. An estimate of overdiagnosis 15 years after the start of mammographic screening in Florence. Eur J Cancer. 2009;45(18):3166–71. doi:10.1016/j.ejca.2009.06.014.

    PubMed  Article  Google Scholar 

  7. 7.

    Jorgensen KJ, Zahl PH, Gotzsche PC. Overdiagnosis in organised mammography screening in Denmark. A comparative study. BMC Women’s Health. 2009;9:36. doi:10.1186/1472-6874-9-36.

    PubMed  Article  PubMed Central  Google Scholar 

  8. 8.

    de Gelder R, Heijnsdijk EA, van Ravesteyn NT, Fracheboud J, Draisma G, de Koning HJ. Interpreting overdiagnosis estimates in population-based mammography screening. Epidemiol Rev. 2011;33(1):111–21. doi:10.1093/epirev/mxr009.

    PubMed  Article  PubMed Central  Google Scholar 

  9. 9.

    Kalager M, Adami HO, Bretthauer M, Tamimi RM. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program. Ann Intern Med. 2012;156(7):491–9. doi:10.7326/0003-4819-156-7-201204030-00005.

    PubMed  Article  Google Scholar 

  10. 10.

    Falk RS, Hofvind S, Skaane P, Haldorsen T. Overdiagnosis among women attending a population-based mammography screening program. Int J Cancer. 2013;133(3):705–12. doi:10.1002/ijc.28052.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  11. 11.

    Welch HG, Passow HJ. Quantifying the benefits and harms of screening mammography. JAMA Intern Med. 2014;174(3):448–54. doi:10.1001/jamainternmed.2013.13635.

    PubMed  Article  Google Scholar 

  12. 12.

    Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet. 2012;380(9855):1778–86. doi:10.1016/S0140-6736(12)61611-0.

    Article  Google Scholar 

  13. 13.

    Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M. The benefits and harms of breast cancer screening: an independent review. Br J Cancer. 2013;108(11):2205–40. doi:10.1038/bjc.2013.177.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  14. 14.

    International Agency for Research on Cancer (IARC). IARC handbooks of cancer prevention—breast cancer screening. Geneva: World Health Organisation; 2002.

    Google Scholar 

  15. 15.

    Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst. 2010;102(9):605–13. doi:10.1093/jnci/djq099.

    PubMed  Article  Google Scholar 

  16. 16.

    Grobin W. Diabetes in the aged: underdiagnosis and overtreatment. Can Med Assoc J. 1970;103(9):915–23.

    PubMed  CAS  PubMed Central  Google Scholar 

  17. 17.

    Feinstein AR, Esdaile JM. Incidence, prevalence, and evidence. Scientific problems in epidemiologic statistics for the occurrence of cancer. Am J Med. 1987;82(1):113–23.

    PubMed  Article  CAS  Google Scholar 

  18. 18.

    Morrison A. Screening in chronic disease. New York: Oxford University Press; 1985.

    Google Scholar 

  19. 19.

    Black WC. Overdiagnosis: an underrecognized cause of confusion and harm in cancer screening. J Natl Cancer Inst. 2000;92(16):1280–2.

    PubMed  Article  CAS  Google Scholar 

  20. 20.

    Etzioni R, Penson DF, Legler JM, et al. Overdiagnosis due to prostate-specific antigen screening: lessons from US prostate cancer incidence trends. J Natl Cancer Inst. 2002;94(13):981–90.

    PubMed  Article  Google Scholar 

  21. 21.

    Hofmann B. The technological invention of disease—on disease, technology and values. Oslo: Universitetet i Oslo; 2002.

    Google Scholar 

  22. 22.

    King L. What is a disease? Philos Sci. 1954;21:193–203.

    Article  Google Scholar 

  23. 23.

    Reznek L. The nature of disease. New York: Routledge & Keagen Paul; 1987.

    Google Scholar 

Download references

Conflict of interest

I certify that there is no conflict of interest in relation to this manuscript, and there are no financial arrangements or arrangements with respect to the content of this manuscript with any companies or organizations. The manuscript is not published elsewhere.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Bjorn Hofmann.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Hofmann, B. Diagnosing overdiagnosis: conceptual challenges and suggested solutions. Eur J Epidemiol 29, 599–604 (2014). https://doi.org/10.1007/s10654-014-9920-5

Download citation

Keywords

  • Common Definition
  • Early Testing
  • Health Care Spending
  • False Negative Test
  • False Positive Test Result